Clinical trials in Odense – page 4

487 clinical trials in Odense, Denmark across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in DenmarkKliniske-Forsoeg.dk

Odense at a glance

487

clinical trials

Research sites4

Quick filters

487 trials in Odense

Open in trial search

Bronchiectasis

Recruiting

A study to evaluate the safety and effectiveness of AZD0292 in people aged 12 years and older with bronchiectasis and chronic Pseudomonas aeruginosa infection

Investigational

A study to evaluate the safety and effectiveness of AZD0292 in people aged 12 years and older with bronchiectasis and chronic Pseudomonas aeruginosa infection

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:AZD0292
Sponsor:AstraZeneca AB

Contact Research Centre

Colitis ulcerative

Recruiting

A study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis

Investigational

A study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:Mirikizumab
Sponsor:Eli Lilly & Co.

Contact Research Centre

Acute myocardial infarction

Recruiting

A study evaluating the effect of methylprednisolone compared to sodium chloride in patients with a heart attack

Registered drug

A study evaluating the effect of methylprednisolone compared to sodium chloride in patients with a heart attack

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Methylprednisolone
Sponsor:Rigshospitalet

Contact Research Centre

Waldenstrom's macroglobulinaemia+2

Recruiting

A study to evaluate the effectiveness of epcoritamab in patients with Waldenström's macroglobulinemia that has returned or has not responded to previous treatments.

InvestigationalNo placebo

A study to evaluate the effectiveness of epcoritamab in patients with Waldenström's macroglobulinemia that has returned or has not responded to previous treatments.

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Epcoritamab
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

Secondary progressive multiple sclerosis

Recruiting

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:Remibrutinib
Sponsor:Novartis Pharma AG

Contact Research Centre

Clostridium difficile infection

Recruiting

A study to evaluate the effectiveness of AZD5148 in preventing the recurrence of Clostridioides difficile infection in adults.

Investigational

A study to evaluate the effectiveness of AZD5148 in preventing the recurrence of Clostridioides difficile infection in adults.

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:AZD5148
Sponsor:AstraZeneca AB

Contact Research Centre

Acute kidney injury

Recruiting

A study testing how well AZD4144 works and how safe it is for adults with acute kidney injury caused by sepsis

Investigational

A study testing how well AZD4144 works and how safe it is for adults with acute kidney injury caused by sepsis

Investigational

Denmark

Participants:18–64 years · 65+ years
Sponsor:AstraZeneca AB

Contact Research Centre

Cardiac amyloidosis

Recruiting

A study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy

Investigational

A study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:Coramitug
Sponsor:Novo Nordisk A/S

Contact Research Centre

Neoplasm malignant+1

Recruiting

Study of ECI830, ribociclib, and fulvestrant in patients with advanced hormone receptor positive, HER2-negative breast cancer and advanced solid tumors

Registered drugNo placebo

Study of ECI830, ribociclib, and fulvestrant in patients with advanced hormone receptor positive, HER2-negative breast cancer and advanced solid tumors

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Fulvestrant
Sponsor:Novartis Pharma AG

Contact Research Centre

Bronchiectasis

Recruiting

A study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis

Investigational

A study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:GSK3862995B
Sponsor:GSK PLC

Contact Research Centre

Acute myeloid leukaemia

Recruiting

A study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.

Investigational

A study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:Bleximenib
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

Human papilloma virus immunisation

Recruiting

A study on the long-term effectiveness and safety of nine-valent human papillomavirus vaccine in women aged 16 to 26 years for prevention of cervical cancer

Registered drugNo placebo

A study on the long-term effectiveness and safety of nine-valent human papillomavirus vaccine in women aged 16 to 26 years for prevention of cervical cancer

Registered drugNo placebo

Denmark

Participants:18–64 years · Healthy volunteers
Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Odense

What the registry says about research in the country

01 Respiratory and Pulmonary Research

Clinical investigations focusing on Idiopathic Pulmonary Fibrosis and chronic respiratory conditions. Studies evaluating new therapeutic approaches for managing nasal polyps and chronic rhinosinusitis.

Pulmonary Fibrosis Treatment
Nasal Polyps Management
Chronic Rhinosinusitis

Trials aim to assess innovative treatments and monitor long-term disease control.

02 Oncology Studies

Comprehensive research into various cancer types, including bladder cancer, metastatic breast cancer, and prostate cancer. Focus on innovative therapies and treatment combinations.

Cancer-Related Fatigue
Advanced Breast Cancer
Prostate Cancer Therapy

Studies evaluate novel treatment approaches and drug combinations for better patient outcomes.

03 Autoimmune and Inflammatory Conditions

Research focusing on Inflammatory Bowel Disease, including Crohn's Disease and Ulcerative Colitis. Studies of treatments for Sjögren's Syndrome and immune thrombocytopenia.

Gastrointestinal Disorders
Immune System Disorders
Chronic Inflammatory Conditions

Trials assess both established and experimental therapies for inflammatory conditions.

04 Cardiovascular and Renal Studies

Investigations into chronic kidney disease, heart conditions, and transplant outcomes. Research includes studies on aortic stenosis and myocardial infarction treatments.

Kidney Transplantation
Cardiac Conditions
Renal Disorders

Focus on improving treatment outcomes and patient care in cardiovascular and renal conditions.

Back to Denmark All countries